193 related articles for article (PubMed ID: 23432600)
1. Prevalence of Helicobacter pylori infection and the effect of its eradication on symptoms of functional dyspepsia in Kashmir, India.
Sodhi JS; Javid G; Zargar SA; Tufail S; Shah A; Khan BA; Yattoo GN; Gulzar GM; Khan MA; Lone MI; Saif Ru; Parveen S; Shoukat A
J Gastroenterol Hepatol; 2013 May; 28(5):808-13. PubMed ID: 23432600
[TBL] [Abstract][Full Text] [Related]
2. Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia.
Veldhuyzen van Zanten S; Fedorak RN; Lambert J; Cohen L; Vanjaka A
Am J Gastroenterol; 2003 Sep; 98(9):1963-9. PubMed ID: 14499772
[TBL] [Abstract][Full Text] [Related]
3. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
Blum AL; Talley NJ; O'Moráin C; van Zanten SV; Labenz J; Stolte M; Louw JA; Stubberöd A; Theodórs A; Sundin M; Bolling-Sternevald E; Junghard O
N Engl J Med; 1998 Dec; 339(26):1875-81. PubMed ID: 9862942
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
Koskenpato J; Farkkilä M; Sipponen P
Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
Koskenpato J; Färkkilä M; Sipponen P
Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
[TBL] [Abstract][Full Text] [Related]
6. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
[TBL] [Abstract][Full Text] [Related]
7. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
Gisbert JP; Cruzado AI; Garcia-Gravalos R; Pajares JM
Hepatogastroenterology; 2004; 51(55):303-8. PubMed ID: 15011890
[TBL] [Abstract][Full Text] [Related]
8. Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial.
Madisch A; Miehlke S; Neuber F; Morgner A; Kuhlisch E; Rappel S; Lehn N; Bayerdörffer E; Seitz G; Stolte M
Aliment Pharmacol Ther; 2006 Feb; 23(4):473-9. PubMed ID: 16441467
[TBL] [Abstract][Full Text] [Related]
9. Indications for treatment of Helicobacter pylori infection: a systematic overview.
Veldhuyzen van Zanten SJ; Sherman PM
CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.
McColl K; Murray L; El-Omar E; Dickson A; El-Nujumi A; Wirz A; Kelman A; Penny C; Knill-Jones R; Hilditch T
N Engl J Med; 1998 Dec; 339(26):1869-74. PubMed ID: 9862941
[TBL] [Abstract][Full Text] [Related]
11. Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Bojarski C; Epple HJ; Kirstein FW; Fromm M; Bisson S; Riecken EO; Schulzke JD
Z Gastroenterol; 2000 Mar; 38(3):211-9. PubMed ID: 10768243
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
Cindoruk M; Erkan G; Karakan T; Dursun A; Unal S
Helicobacter; 2007 Aug; 12(4):309-16. PubMed ID: 17669103
[TBL] [Abstract][Full Text] [Related]
13. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
Talley NJ; Vakil N; Ballard ED; Fennerty MB
N Engl J Med; 1999 Oct; 341(15):1106-11. PubMed ID: 10511608
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori eradication in functional dyspepsia: HEROES trial.
Mazzoleni LE; Sander GB; Francesconi CF; Mazzoleni F; Uchoa DM; De Bona LR; Milbradt TC; Von Reisswitz PS; Berwanger O; Bressel M; Edelweiss MI; Marini SS; Molina CG; Folador L; Lunkes RP; Heck R; Birkhan OA; Spindler BM; Katz N; Colombo Bda S; Guerrieri PP; Renck LB; Grando E; Hocevar de Moura B; Dahmer FD; Rauber J; Prolla JC
Arch Intern Med; 2011 Nov; 171(21):1929-36. PubMed ID: 22123802
[TBL] [Abstract][Full Text] [Related]
15. Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection?
Kyzekové J; Arlt J; Arltová M
Hepatogastroenterology; 2001; 48(38):594-602. PubMed ID: 11379362
[TBL] [Abstract][Full Text] [Related]
16. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia.
Vakil N; Talley NJ; Stolte M; Sundin M; Junghard O; Bolling-Sternevald E
Aliment Pharmacol Ther; 2006 Jul; 24(1):55-63. PubMed ID: 16803603
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
Froehlich F; Gonvers JJ; Wietlisbach V; Burnand B; Hildebrand P; Schneider C; Saraga E; Beglinger C; Vader JP;
Am J Gastroenterol; 2001 Aug; 96(8):2329-36. PubMed ID: 11513170
[TBL] [Abstract][Full Text] [Related]
18. Functional dyspepsia, H. pylori and post infectious FD.
Fock KM
J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():39-41. PubMed ID: 21443707
[TBL] [Abstract][Full Text] [Related]
19. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
20. Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate--a placebo-controlled study.
Nseir W; Diab H; Mahamid M; Abu-Elheja O; Samara M; Abid A; Mograbi J
Aliment Pharmacol Ther; 2012 Aug; 36(3):231-8. PubMed ID: 22646167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
